Viewing Study NCT02595450


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT02595450
Status: COMPLETED
Last Update Posted: 2016-01-25
First Post: 2015-11-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ML22190
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators